Biopharma Facility Spare Parts Review – Path to Lowering Mean Time To Repair
About the Client
Our client, one of the largest pharmaceutical companies in the world, hired Transcat to perform a Spare Parts Review in high-risk departments.
Business Challenge
The client was targeting a reduction in Mean Time To Repair (MTTR) as part of a greater Overall Equipment Effectiveness (OEE) initiative. Parts were entered into the onsite stock room during Validation activities. However, if parts were not used in 24- months, they were eliminated from stock causing unavailability during repair. In addition, the client had limited internal resources to research parts, form vendor relationships, and proactively stock according to their needs. The client identified the lack of Spare Parts availability as a high-risk to Planned Production Time. Lastly, a loss of confidence in storeroom practices resulted in parts being held in desk drawers, toolboxes and electrical enclosures. This limited the availability of parts to only those who were aware of this ad-hoc retention process, and reduced visibility on actual stock levels.
Project Challenges
The Project involved equipment that had been identified as a potential bottleneck to production, therefore, the Transcat team needed to move quickly to resolve the issues. Much of the identified equipment was considered “legacy” (over 20 years old and up to 30 years of continued use), which meant documentation was also a challenge.
Upgrades that had been carried out by vendors, engineering, and maintenance had varying levels of documentation which needed to be resolved. Competing incentives between Engineering and Procurement (stores) for equipment uptime and cost reductions required careful attention and navigation. There was also a perception of minimal efficiency gains being achieved by the project when compared with the time investment required which limited initial participation by equipment SMEs.